10101 Park Rowe Avenue Baton Rouge, Louisiana 70810

Clinic: (225) 769-2200  / 

Spine Hospital: (225) 763-9900  / 

Rehab: (225) 906-3838

Three Entities, One Family. Choose Your Destination:

Clinical Trials

At The NeuroMedical Center, we are dedicated to helping our patients live longer, healthier lives. Through clinical research studies, our experts depend on human volunteers to find better ways to prevent, diagnose and treat neurological diseases and conditions. Our Clinical Research Department is currently screening for participants for the following studies:

Parkinson’s Disease Clinical Trial (no study length indicated)
A clinical research study for patients diagnosed with Parkinson's Disease who are experiencing involuntary movements (called dyskinesias) that are caused by levodopa treatment. Criteria:
  • Must be 30-85 years old
  • Diagnosed with Parkinson's Disease
  • Are experiencing troublesome or problematic dyskinesias (involuntary muscle movements, swaying, moving too much)
  • Are on a stable dose of oral medication for Parkinson's Disease
  • Are able to complete an accurate home diary
If you qualify for this study you will receive free study medication, study-related care and may be compensated for time and travel.
Multiple Sclerosis Clinical Trial (appx. 15 months)
A clinical research study that is looking at the impact of two different approved medications for MS on tissue damage in the central nervous system (brain and spinal cord) caused by MS. Criteria:
  • Must be 18-60 years old
  • Diagnosed with relapsing/remitting MS
  • Do not have any metal devices ( e.g. cardiac pacemaker) or possible metal fragments in body that would prevent you from having MRI scans
If you qualify for this study you will receive free study medication, study-related care and may be compensated for time and travel.
Chronic Migraine Clinical Trial (appx. 9 months)
A phase-4, open-label research study to compare the efficacy, safety and tolerability of prophylactic treatment with BOTOX and topiramate in adults with chronic migraine. Criteria:
  • Must be 18-65 years old
  • Diagnosed with chronic migraine
  • Patient must be na├»ve to both botulinum toxin of any serotype and topiramate for any reason
If you qualify for this study you will receive free study medication, study-related care and may be compensated for time and travel.

Taking part in a clinical research study is an important decision and one you may want to discuss with your family or primary doctor.

For more information on any clinical trial offered at The NeuroMedical Center, including how to enroll, please contact Jan Loyacano, RN at (225) 761-2569.